Program
9:00AM-9:25AM: Registration.
9:25PM-9:30PM: Opening remarks. Ken Breslauer, VP of Life and Health Science, Rutgers University.
9:30PM-10:05PM: Session I: "New Frontiers in Biopharmaceutical research"
Chair: Jose Alvir, Pfizer.
David Madigan, Rutgers University. "High-dimensional logistic regression: Recent developments and novel applications".
10:15PM-12:00PM: Session II: "New developments in clinical studies Part I"
Chair: Dirk Moore, UMDNJ.,
Leonard Oppenheimer, Johnson & Johnson. "Extension Studies"
Mani Lakshminarayanan Pfizer. "Handling Count Data in Clinical Trials"
Hui Quan, Sanofi-Aventis, "Analysis of a Composite Endpoint with Missing Data in Components"
12:00PM-1:15PM: Lunch Break
1:15PM-2:25PM: Session III "New developments in clinical studies Part II"
Chair: James Colaianne, Johnson & Johnson.
Jose Pinheiro, Novartis. "Evaluating Adaptive Dose-Ranging Studies and Methods: A Report from the PhRMA Working Group"
Vladimir Dragalin, Wyeth. "Adaptive model-based designs in clinical drug development"
2:40PM-4:25PM: Session IV: "Bayesian methodology application in clinical studies"
Chair: William Mietlowski. Novartis.
Inna Perevozskaya, Merck. "Bayesian Optimal Designs for Phase I Clinical Trials in Oncology"
Pablo Bonangelino, Food and Drug Administration. "Bayesian Designs for Therapeutic Medical Device Trials".
William E. Strawderman, Rutgers University. "Combining Biased and Unbiased Estimates in High Dimensions".
5:30PM-7:00PM: Reception at the 7th floor lounge of Hill Center.
The wine and cheese reception will
provide a great opportunity for further interaction.
| 
